These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9444894)

  • 1. Risperidone in PDD.
    Fisman S; Steele M; Pipher B
    J Am Acad Child Adolesc Psychiatry; 1998 Jan; 37(1):15-6. PubMed ID: 9444894
    [No Abstract]   [Full Text] [Related]  

  • 2. Risperidone in a very young child with PDD.
    Bober D; Sabzwari U; Star JE
    J Am Acad Child Adolesc Psychiatry; 2005 Aug; 44(8):725-6. PubMed ID: 16034272
    [No Abstract]   [Full Text] [Related]  

  • 3. The autistic-spectrum disorders.
    Rapin I
    N Engl J Med; 2002 Aug; 347(5):302-3. PubMed ID: 12151466
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of risperidone in developmentally disabled children.
    Kastner TA
    Pediatrics; 2005 May; 115(5):1447-8; author reply 1448. PubMed ID: 15867075
    [No Abstract]   [Full Text] [Related]  

  • 5. Risperidone in pervasive developmental disorders.
    Erickson CA; Stigler KA; Posey DJ; McDougle CJ
    Expert Rev Neurother; 2005 Nov; 5(6):713-9. PubMed ID: 16274329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone use in autism spectrum disorders: a retrospective review of a clinic-referred patient population.
    Lemmon ME; Gregas M; Jeste SS
    J Child Neurol; 2011 Apr; 26(4):428-32. PubMed ID: 20929907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open trial of risperidone in 24 young children with pervasive developmental disorders.
    Masi G; Cosenza A; Mucci M; Brovedani P
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1206-14. PubMed ID: 11589534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of long-term use of risperidone on body weight of children with an autism spectrum disorder.
    Demb H; Valicenti-McDermott M; Navarro A; Ayoob KT
    J Clin Psychopharmacol; 2011 Oct; 31(5):669-70. PubMed ID: 21881456
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive quetiapine may help depression comorbid with pervasive developmental disorders.
    Tufan AE; Kutlu H
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1570-1. PubMed ID: 19758575
    [No Abstract]   [Full Text] [Related]  

  • 12. Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.
    McDougle CJ; Holmes JP; Bronson MR; Anderson GM; Volkmar FR; Price LH; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):685-93. PubMed ID: 9136504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review.
    Frazier JA; Meyer MC; Biederman J; Wozniak J; Wilens TE; Spencer TJ; Kim GS; Shapiro S
    J Am Acad Child Adolesc Psychiatry; 1999 Aug; 38(8):960-5. PubMed ID: 10434487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone: a potential treatment for autism.
    Posey DJ; McDougle CJ
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1212-6. PubMed ID: 12211417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of medication in pervasive developmental disorders.
    Sloman L
    Psychiatr Clin North Am; 1991 Mar; 14(1):165-82. PubMed ID: 1675463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
    Hamrin V; McDonnell MA; Moffett J; Durso S
    Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tics and risperidone.
    Diantoniis MR; Henry KM; Partridge PA; Soucar E
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):839-40. PubMed ID: 8768339
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolactin release in children treated with risperidone: impact and role of CYP2D6 metabolism.
    Troost PW; Lahuis BE; Hermans MH; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
    J Clin Psychopharmacol; 2007 Feb; 27(1):52-7. PubMed ID: 17224713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone and parent training in pervasive developmental disorders.
    van Haaren F
    J Am Acad Child Adolesc Psychiatry; 2010 Apr; 49(4):406-7; author reply 407-8. PubMed ID: 20410733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.